Session Information
2007 Midyear Clinical Meeting
Over-the-Counter Cold Medicines: What's the Future for Pediatric Use?
Track: Educational Session
Program Code: 269-L04
Date: Tuesday, December 4, 2007
Time: 4:00 p.m. - 5:00 p.m.
Location:
Veronese 2405/2406MEETING PLANNING ASSOCIATE:
Dr. Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation
MODERATOR:
Dr. Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation
PRESENTER:
Dr. Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation
LEARNING OBJECTIVES
- Describe the recent FDA discussions regarding the safety of non-prescription cough, cold, bronchodilator, and antiasthmatic medications in children.
- List the common toxicities in children associated with cough, cold, bronchodilator, and antiasthmatic medications.
- Name specific patient cases of toxicity from cough, cold, bronchodilator, and antiasthmatic medications that led to the October 2007 FDA hearings regarding their use in children.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 269-L04)
This session is a part of: